MYPS
PLAYSTUDIOS, Inc.
MYPS has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over MYPS overall, supported by stronger fundamentals and stronger modeled upside.
MYPS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Stable | |
| Strong |
MYPS's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
MYPS PE Valuation
MYPS has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
MYPS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MYPS's losses to shrink, with revenue declining.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over MYPS on the outlook, with more favorable revenue expectations.
MYPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.92 | -$1.02 |
| Q2 2026 | -$3.70 | -$1.30 |
| Q1 2026 | -$2.90 | -$0.50 |
| Q4 2025 | -$2.30 | -$0.10 |
| Q3 2025 | -$2.90 | -$1.00 |
| Q2 2025 | -$2.40 | -$1.00 |
| Q1 2025 | -$2.40 | -$1.10 |
| Q4 2024 | -$2.20 | -$0.70 |
MYPS lost $3.92 per share over the past year, a bigger loss than the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over MYPS in the latest year-over-year earnings comparison.
MYPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.9M | -15% |
| Q2 2026 | $55M | -7.3% |
| Q1 2026 | $58.4M | -6.9% |
| Q4 2025 | $55.4M | -18% |
| Q3 2025 | $57.6M | -19% |
| Q2 2025 | $59.3M | -18% |
| Q1 2025 | $62.7M | -19% |
| Q4 2024 | $67.8M | -12% |
MYPS's revenue has slid since its 2023 peak: $49M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -40% | -27 points |
| Q2 2026 | -17% | -12 points |
| Q1 2026 | -23% | -18 points |
| Q4 2025 | -18% | +15 points |
| Q3 2025 | -14% | -6.9 points |
| Q2 2025 | -5.9% | -0.4 points |
| Q1 2025 | -4.4% | -2.2 points |
| Q4 2024 | -33% | -30 points |
MYPS's operating margin was −40% last quarter, down 27 points from the same quarter a year ago, near the bottom of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over MYPS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over MYPS on profitability, with a higher operating margin.
MYPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.6M | +42% |
| Q2 2026 | $5.4M | -59% |
| Q1 2026 | $3.7M | +15% |
| Q4 2025 | $3.6M | -69% |
| Q3 2025 | $5.4M | -62% |
| Q2 2025 | $13.2M | +3.4% |
| Q1 2025 | $3.2M | -10% |
| Q4 2024 | $11.5M | -19% |
MYPS still generates free cash flow, though less than at its 2020 peak: $20M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over MYPS on cash flow, with more consistent year-over-year improvement.
MYPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -25.2x | Net Cash |
| Q4 2025 | -7.3x | Net Cash |
| Q3 2025 | -36.8x | Net Cash |
| Q2 2025 | -14.2x | Net Cash |
| Q1 2025 | -11.0x | Net Cash |
| Q4 2024 | -8.6x | Net Cash |
| Q3 2024 | -3.2x | Net Cash |
| Q2 2024 | -3.1x | Net Cash |
MYPS has more cash than debt.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
MYPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 29.3 | Neutral |
MYPS's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
MYPS PE vs Technology Sector
| Metric | MYPS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MYPS has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
MYPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.45 | 8.1% above |
| 20 week MA | $5.36 | 10% below |
| 50 week MA | $5.39 | 11% below |
| 100 week MA | $9.16 | 47% below |
| 200 week MA | $19.1 | 75% below |
MYPS has stronger trend alignment. MYPS is above 1 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
MYPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $100.5 | $100.5 | 0% |
| 2021 | $100.5 | $41.8 | -58% |
| 2022 | $41.8 | $37.7 | -9.8% |
| 2023 | $37.7 | $27.1 | -28% |
| 2024 | $27.1 | $19.1 | -30% |
| 2025 | $19.1 | $6.76 | -65% |
| 2026 YTD | $6.76 | $4.81 | -29% |
MYPS has finished every year since 2020 lower, and it's down 29% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over MYPS on returns for 2026, with the stronger performance.